Mirna Perez

Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020

Laura D. Zambrano, Sascha Ellington, Penelope Strid et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 1.3K citations · Full text

Medicine, Infectious Diseases, Obstetrics +17

Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Kate R. Woodworth, Emily O’Malley Olsen, Varsha Neelam et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 415 citations · Full text

Public Health, Infectious Diseases, Obstetrics +17

Risk Factors for Illness Severity Among Pregnant Women With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection—Surveillance for Emerging Threats to Mothers and Babies Network, 22 State, Local, and Territorial Health Departments, 29 March 2020–5 March 2021

Romeo R. Galang, Suzanne Newton, Kate R. Woodworth et al. · Clinical Infectious Diseases · 2021 · 115 citations · Full text

Public Health, Infectious Diseases, Maternal Health +17

Andrographolide Inhibits IFN-γ and IL-2 Cytokine Production and Protects Against Cell Apoptosis

Rafael A. Burgos, Karina Seguel, Mirna Perez et al. · Planta Medica · 2005 · 61 citations · Full text

Life Sciences, Immunology, Pharmacology +17

The Centers for Disease Control and Prevention's maternal health response to 2009 H1N1 influenza

Laura G. Mosby, Sascha Ellington, Sara E. Forhan et al. · American Journal of Obstetrics and Gynecology · 2011 · 27 citations

Public Health, Maternal Health, Obstetrics +16